MedinCell S.A.

MedinCell S.A.

MDCLF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.04B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
MedinCell S.A.MedinCell S.A.-31.7--1623%30.318.7

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.04 Billion
Enterprise Value$1.03 Billion
Earnings per Share$-0.87
Beta1
Outstanding Shares35,904,000

Return

Return on Equity-1622.88%ROE
Return on Assets-46.02%
Return on Invested Capital-51.85%

Valuation & Multiples

P/E Ratio-31.67P/E Ratio
PEG-10.81PEG
Price to Sales30.26Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue22.89
Enterprise Value to EBIT-22.77
Enterprise Value to Net Income-21
Total Debt to Enterprise0.06
Debt to Equity18.74Debt to Equity

Revenue Sources

No data

Next Earnings Call

Expected Date
December 8, 2026
EPS Estimate
-$0.12
Consensus analyst estimate
Revenue Estimate
$19.26 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About MedinCell S.A.

150 employees
CEO: Christophe Douat

MedinCell S.A. is a pharmaceutical company dedicated to creating a diverse array of medical treatments. At the heart of its innovation is the BEPO platform, a unique technology designed for long-acting injectable drugs. This system utili...

Questions & Answers